Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(15)2023 Jul 28.
Article in English | MEDLINE | ID: mdl-37569513

ABSTRACT

The lactoperoxidase (LPO) system shows promise in the prevention of dental caries, a common chronic disease. This system has antimicrobial properties and is part of the non-specific antimicrobial immune system. Understanding the efficacy of the LPO system in the fight against biofilms could provide information on alternative strategies for the prevention and treatment of caries. In this study, the enzymatic system was modified using four different (pseudo)halide substrates (thiocyanate, thiocyanate-iodide mixture, selenocyanate, and iodide). The study evaluated the metabolic effects of applying such modifications to Streptococcus mutans; in particular: (1) biofilm formation, (2) synthesis of insoluble polysaccharides, (3) lactate synthesis, (4) glucose and sucrose consumption, (5) intracellular NAD+ and NADH concentrations, and (6) transmembrane glucose transport efficiency (PTS activity). The results showed that the LPO-iodide system had the strongest inhibitory effect on biofilm growth and lactate synthesis (complete inhibition). This was associated with an increase in the NAD+/NADH ratio and an inhibition of glucose PTS activity. The LPO-selenocyanate system showed a moderate inhibitory effect on biofilm biomass growth and lactate synthesis. The other systems showed relatively small inhibition of lactate synthesis and glucose PTS but no effect on the growth of biofilm biomass. This study provides a basis for further research on the use of alternative substrates with the LPO system, particularly the LPO-iodide system, in the prevention and control of biofilm-related diseases.


Subject(s)
Anti-Infective Agents , Dental Caries , Humans , Streptococcus mutans , Thiocyanates/pharmacology , Lactoperoxidase/pharmacology , Lactoperoxidase/metabolism , NAD/metabolism , Iodides/metabolism , Biofilms , Anti-Infective Agents/pharmacology , Glucose/metabolism , Lactates/metabolism
2.
Int J Mol Sci ; 24(3)2023 Jan 30.
Article in English | MEDLINE | ID: mdl-36768964

ABSTRACT

One strategy in caries prevention is to inhibit the formation of cariogenic biofilms. Attempts are being made to develop oral hygiene products enriched with various antimicrobial agents. One of them is lactoperoxidase-an enzyme that can oxidise (pseudo)halide ions to reactive products with antimicrobial activity. Currently, commercially available products utilise thiocyanate as a substrate; however, several alternatives that are oxidised to products with greater antimicrobial potential have been found. In this study, toxicity against human gingival fibroblasts of the lactoperoxidase system was evaluated using four different (pseudo)halide substrate systems-thiocyanate, iodide, selenocyanate, and a mixture of thiocyanate and iodide. For this purpose, cells were treated with the systems and then apoptosis, cell cycle, intracellular glutathione concentration, and mitochondrial superoxide production were assessed. The results showed that each system, after generating 250 µM of the product, inhibited cell divisions, increased apoptosis, and increased the percentage of dead cells. It was concluded that the mechanism of the observed phenomena was not related to increased superoxide production or the depletion of glutathione concentration. These findings emphasised the need for the further in vitro and in vivo toxicity investigation of the modified lactoperoxidase system to assess its safety and the possibility of use in oral hygiene products.


Subject(s)
Lactoperoxidase , Thiocyanates , Humans , Fibroblasts/metabolism , Hydrogen Peroxide/pharmacology , Iodides/metabolism , Lactoperoxidase/metabolism , Superoxides , Thiocyanates/pharmacology , Gingiva/metabolism
3.
Cent Eur J Immunol ; 48(4): 350-357, 2023.
Article in English | MEDLINE | ID: mdl-38558560

ABSTRACT

Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently described disease characterized by recurrent infections, lymphoproliferation with a high risk of malignancy, early-onset cytopenia, and a propensity for autoimmune diseases. Hematopoietic stem cell transplantation (HSCT) has proven to be an effective treatment method; however, the recovery process after HSCT is prolonged and accompanied by complications. In this study, we present the case of a patient with APDS type 1. Despite showing signs of immunodeficiency at the age of 6 months, it took almost 6 years to reach a definitive diagnosis. The patient experienced recurrent infections, often accompanied by anemia requiring transfusions, and multifocal nonmalignant lymphoproliferation. Only after receiving the appropriate diagnosis was it possible to implement proper and accurate treatment. HSCT was performed when the patient was 6 years old, leading to significant improvement in his condition. At the 17-month post-HSCT follow-up, the boy is asymptomatic and in good general health, although close monitoring continues due to mixed chimerism and delayed humoral immune recovery. Applying HSCT before the patient develops malignancy contributes to expanding the use of HSCT as a treatment option for APDS type 1.

4.
Cells ; 11(6)2022 03 10.
Article in English | MEDLINE | ID: mdl-35326407

ABSTRACT

Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Currently, NSCLC therapy is based on the analysis of specific predictors, whose presence qualifies patients for appropriate treatment. Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5), also known as "survivin", is a protein whose expression is characteristic for most malignant tumors and fetal tissue, while absent in mature cells. The biological role of BIRC5 is to counteract apoptosis by inhibiting the initiating and effector activities of caspases and binding to microtubules of the mitotic spindle. In our study, we looked for a relationship between BIRC5 gene polymorphism and the effectiveness of platinum-based chemotherapy. The study group consisted of 104 patients with newly diagnosed locally advanced or metastatic NSCLC. DNA was isolated from pretreatment blood samples, and SNPs of BIRC5 gene were analyzed. All patients received first-line platinum-based chemotherapy. Univariate analysis showed that a specific BIRC5 genotype was significantly associated with a higher risk of early progression (homozygous GG vs. heterozygous CG or CC: 28.9% vs. 11.9%). The presence of a homozygous GG genotype of the BIRC5 gene was insignificantly related to PFS shortening and TTP shortening. Moreover, significantly higher risk of overall survival shortening was associated with the BIRC5 homozygous GG genotype. Thus, studies on polymorphisms of selected genes affecting apoptosis may have a practical benefit for clinicians who monitor and treat NSCLC.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Apoptosis/genetics , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/genetics , Humans , Inhibitor of Apoptosis Proteins/genetics , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Polymorphism, Single Nucleotide/genetics , Survivin/genetics
5.
J Clin Med ; 10(5)2021 Mar 08.
Article in English | MEDLINE | ID: mdl-33800294

ABSTRACT

Caspase 8 is a protein involved in the process of cell apoptosis, which may affect the efficacy of anti-cancer treatment. The aim of our study was to determine the impact of polymorphisms in the CASP-8 gene encoding caspase 8 on the prognosis in non-small-cell lung cancer (NSCLC). The study involved 99 patients with newly diagnosed locally advanced or metastatic NSCLC treated with platinum-based chemotherapy. The presence of the GG genotype was associated with distant metastases, smoking, and a family history of cancer. The higher risk of early progression was associated with weight loss and the CASP-8 genotype (GG vs. AG or AA: 20.51% vs. 2.86%). The higher risk of progression-free survival (PFS) shortening was associated with a higher stage of disease (hazard ratio (HR) = 2.50, 95% CI: 1.61-3.89, p < 0.0001), distant metastases (HR = 2.30, 95% CI: 1.42-3.72, p = 0.0016), and the GG genotype (HR = 1.68, 95% CI: 1.10-2.57, p = 0.0152). The influence of the GG genotype on the PFS was confirmed in a multivariate analysis (HR = 1.80, 95% CI: 1.06-3.05, p = 0.0317). We did not confirm the influence of CASP-8 genotypes on the overall survival (OS).

6.
Materials (Basel) ; 12(19)2019 Sep 30.
Article in English | MEDLINE | ID: mdl-31575026

ABSTRACT

Zeolites, naturally possessing a high negative surface charge and large specific surface, are used in agriculture as cationic fertilizers, water holders, heavy metals, and organic pollutants sorbents. Since some nutrients occur in anionic forms, there is a need to modify the zeolite surface to hold anions. In this study, hydrogen (hydrochloric acid), iron (Fe2+ and Fe3+), and aluminum cations as well as the influence of sodium hydroxide modifiers on the specific surface area, water vapor, adsorption energy, fractal dimension, mesopore volumes and radii, electrokinetic (zeta) potential, and isoelectric point were investigated. The use of alkali solution did not affect the zeolite properties significantly, whereas hydrogen, iron, and treatments with aluminum cations resulted in an increase in the specific surface area, mesopore volumes, and radii, and a decrease in the water-binding forces. Aluminum cations were the most effective in recharging the zeolite surface from negative to positive, shifting the isoelectric point toward the highest values. Calcination enlarged the negative surface charge and mesopore radius, and diminished the surface area and mesopore volume. The modified zeolites are promising carriers of anionic nutrients, large surface area sorbents, and suppliers of water for plant roots in soil.

7.
Int J Mol Sci ; 20(6)2019 Mar 21.
Article in English | MEDLINE | ID: mdl-30901933

ABSTRACT

Lactoperoxidase (LPO) present in saliva are an important element of the nonspecific immune response involved in maintaining oral health. The main role of this enzyme is to oxidize salivary thiocyanate ions (SCN-) in the presence of hydrogen peroxide (H2O2) to products that exhibit antimicrobial activity. LPO derived from bovine milk has found an application in food, cosmetics, and medical industries due to its structural and functional similarity to the human enzyme. Oral hygiene products enriched with the LPO system constitute an alternative to the classic fluoride caries prophylaxis. This review describes the physiological role of human salivary lactoperoxidase and compares the results of clinical trials and in vitro studies of LPO alone and complex dentifrices enriched with bovine LPO. The role of reactivators and inhibitors of LPO is discussed together with the possibility of using nanoparticles to increase the stabilization and activity of this enzyme.


Subject(s)
Lactoperoxidase/metabolism , Lactoperoxidase/pharmacology , Oral Health , Oral Hygiene , Animals , Biotechnology , Chemical Phenomena , Clinical Trials as Topic , Dental Caries/prevention & control , Humans , Lactoperoxidase/chemistry , Lactoperoxidase/genetics , Oxidation-Reduction/drug effects , Periodontitis/prevention & control , Saliva/metabolism , Structure-Activity Relationship , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...